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there is fever or hypothermia, tachycardia, tachypnea,
leukocytosis or leucopenia and elevated CRP serum levels.
The diagnosis of sepsis requires evidence of infection.
Procalcitonin (PCT) serum levels are elevated only in septic
condition.
Objective: To correlate PCT with CRP, white blood cells
(WBC) and temperature (0T) of patients with SIRS in order
to conclude if PCT serum levels can attribute to the decision
if empirical antibiotic treatment should be administered
or not.
Material and Method: Ninety nine patients with SIRS were
enrolled in the study. PCT, CRP and 0T were determined.
The patients were divided in two groups. The ﬁrst group
consisted of patients with PCT 1 ng/ml and the other
group by patients with PCT> 1 ng/ml. The second group
was assumed as more susceptible to sepsis. We performed
Spearman correlation between PCT serum levels and CRP,
WBC and temperature (statistical signiﬁcance a = 0.05).
Results: In 54 patients with PCT 1 ng/ml there was no
statistical signiﬁcant correlation. On the other hand in the
remaining 45 patients with PCT> 1 ng/ml there was found
statistically signiﬁcant positive correlation (p < 0.05). Six of
the 54 while having normal PCT 1 ng/ml they had CRP
20mg/ml, WBC 20,000/mm3 and ºT 38.2.
Conclusions: The administration of antibiotics to the
patients with PCT 1 ng/ml would be unnecessary. The
patients with PCT >1 ng/ml should be given empirical
treatment especially to patients with PCT 5 ng/ml even
with negative blood cultures.
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Background: Chronic liver injury is caused by a variety of
injuries, including viral hepatitis, alcohol and drug abuse,
and autoimmune hepatitis. Liver ﬁbrosis is a process of
chronic liver injuries, characterized by increased synthesize
and decreased degradation of extracellular matrix (ECM),
ECM deposition in the liver and altered the normal liver
architecture and function. The present study aims the
changes of liver tissue NF-úB pathway and apoptosis-related
genes in experimental mice hepatic ﬁbrosis.
Methods: C57BL6/J mice were divided into model group
and control group, two group mice were injected with CCL4
or Sodium Chloride for 8 weeks to induce hepatic ﬁbrosis.
Blood and liver tissue was harvested from the mice. The
expression of a-SMA, NF-úB/IúBp65 and apoptosis-related
genes caspases3, Bcl-2/Bax in liver tissue was measured by
immunohistochemistry and RT-PCR assay. Serum ALT and HA
were measured.
Result: CCL4 induced hepatic ﬁbrosis models showed
increased serum ALT and HA levels, and progressive hepatic
injury including inﬂammatory inﬁltration and ﬁbrosis, which
associated with enhanced a-SMA, NF-úB, IúBP65 protein and
gene expression. Apoptosis-related gene bax expression was
increased, bcl-2 expression was decreased, caspases3 pro-
tein and gene expression were up-regulated. These effects
were associated with repressed hepatic HSC activation.
Conclusion: Our results demonstrate that NF-úB/IúB signal
pathway and apoptosis-related genes caspases3, bcl-2/bax
play a critical role in the progression of hepatic ﬁbrosis. It
could be useful targets for ﬁbrosis therapy.
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Introduction: Mucormycosis is a rare opportunistic infec-
tion, usually associated with immunocompromised states.
Several conditions such as hematologic malignancy, solid
organ transplantation, diabetes mellitus, corticosteroid
therapy, or chemotherapy predispose patients to infection.
It can produce an aggressive and sometimes fatal infection.
Cerebral mucormycosis is an acute life-threatening disease.
Early inﬁltration of the infectious agent into the central
nervous system may result in septic thrombosis of
the cavernous sinus, mycotic meningoencephalitis, brain
infarctions as well as intracerebral and subarachnoidal
hemorrhages.
Case Description: The patient was a 46 year-old woman
known case of diabetes mellitus with chief complaint
of headache, fever and swelling of right posterior
auricular area with erythema and hotness. Brain CT scan
was performed that showed a brain abscess in right
temporoparietal lobe. Smear of drained abscess showed
broad nonseptated hyphae and culture result was mucoral
agent. Amphotericin B was started. Despite several days
after amphotericin B infusion, fever continued and ESR
did not change. Amphotericin B was discontinued and
posaconazole was started. Fever disappeared and ESR
decreased and the patient was discharged with good
general condition. Isolated cerebral mucormycosis is a
rare and life threatening presentation of mucormycosis.
Resistance to amphotericin B is increasing in mucoral
agents. Mucormycosis has a good response to posaconazole.
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Objectives: Mucormycosis is an aggressive fungal disease
that involves the paranasal sinuses, orbit, central nervous
system and other organs. This infection usually occurs
secondary to immune suppression, diabetic ketoacidosis,
and prolonged use of antibiotics, steroids, and cytotoxic
drugs. Management of the condition consists of treatment of
the underlying disease and surgical debridement combined
with intravenous antifungal agents.
Methods: In a retrospective study we evaluated nine
cases of mucormycosis in several tertiary care hospitals
in Iran during several years. Clinical manifestations,
diagnosis including laboratory and radiologic study,
management including surgical and medical interventions
were evaluated.
Results: In this study there were six cases of rhinocerebral
mucormycosis, one case of pulmonary mucormycosis, one
case of pelvic mucormycosis and one case of isolated
cerebral mucormycosis. Risk factor for most of our
patients was diabetes mellitus. We use amphotericin B and
posaconazole as medical therapy. Surgical intervention and
radical debridement was performed for all of patients. Five
cases (55.5%) of our patients survived. The patients that
